India Drops MNC Negotiation Plans Without New Drug Price Controls

Executive Summary

India's delay in adopting a new drug price control plan has had a fallout effect on other plans to reduce the cost of imported drugs and medical devices. The government had planned to conduct negotiations with multinational drug makers, but canceled them when several ministries involved could not reach agreement on a new price control plan April 30. That failure was attributed to the Health Ministry, the same ministry that had planned to negotiate with the MNCs. (Click here for more